Saturday, November 6, 2021
- 8:30AM-10:30AM
-
Abstract Number: 0010
Relaxed Peripheral Tolerance Drives Broad de Novo Autoreactivity in Severe COVID-19
B Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster (0001–0010)- 8:30AM-10:30AM
-
Abstract Number: 0167
Reliability of a Novel Pediatric Joint-Specific Scoring System for the Elbow, Wrist and Finger Joints
Imaging of Rheumatic Diseases Poster (0149–0182)- 8:30AM-10:30AM
-
Abstract Number: 0304
Renal Involvement in Sjőgren’s Syndrome: Predictors and Impact on Patient Outcome
Sjögren's Syndrome – Basic & Clinical Science Poster (0296–0322)- 8:30AM-10:30AM
-
Abstract Number: 0405
Retrospective Study on the Prognostic Value of Cardiac Magnetic Resonance Imaging Abnormalities in Systemic Sclerosis
Systemic Sclerosis & Related Disorders – Clinical Poster I (0387–0413)- 8:30AM-10:30AM
-
Abstract Number: 0115
Rheumatic Disease Management by Resilient Rheumatology Providers in COVID-19 Pandemic: A National Veterans Affairs Follow-up Survey Assessing Provider Practice and Views Since June 2020
Epidemiology & Public Health Poster I: COVID-19 & Vaccination (0084–0117)- 8:30AM-10:30AM
-
Abstract Number: 0015
Rheumatoid Factor Recognizes Specific Domains of IgG Heavy Chain Complexed with HLA Class II Molecules
RA – Etiology & Pathogenesis Poster (0011–0045)- 8:30AM-10:30AM
-
Abstract Number: 0253
Rheumatoid Factor Status as a Predictor of Disease Activity and Disability:An Analysis of the New CARRA Registry Polyarticular Juvenile Idiopathic Arthritis Cohort
Pediatric Rheumatology – Clinical Poster I: JIA (0241–0265)- 8:30AM-10:30AM
-
Abstract Number: 0145
Rheumatology Provider Perspectives on Using Patient-Reported Outcomes in Clinical Care
Health Services Research Poster I: Lupus, Inflammatory Arthritis, & More (0128–0148)- 8:30AM-10:30AM
-
Abstract Number: 0095
Risk Factors for “Long Haul” COVID-19 in Rheumatology Outpatients in New York City
Epidemiology & Public Health Poster I: COVID-19 & Vaccination (0084–0117)- 8:30AM-10:30AM
-
Abstract Number: 0284
Risk Factors for Dementia in Patients with Incident Rheumatoid Arthritis: A Population-based Cohort Study
RA – Diagnosis, Manifestations, & Outcomes Poster I: Cardiovascular Pulmonary Disease (0268–0295)- 8:30AM-10:30AM
-
Abstract Number: 0285
Risk of Cardiovascular Disease in Newly Diagnosed Rheumatoid Arthritis: A Current Risk Assessment
RA – Diagnosis, Manifestations, & Outcomes Poster I: Cardiovascular Pulmonary Disease (0268–0295)- 8:30AM-10:30AM
-
Abstract Number: 0204
Risk of Hepatitis B Virus Reactivation in Patients with Immune-Mediated Inflammatory Diseases Receiving Biologics: Focus on the Timing of Biologics After Prophylactic Anti-viral Agents
Miscellaneous Rheumatic & Inflammatory Diseases Poster I (0183–0209)- 8:30AM-10:30AM
-
Abstract Number: 0111
Risk of Hospitalization, Admission to Intensive Care and Mortality Due to COVID-19 in Patients with Rheumatic Diseases: A Population-based Matched Cohort Study
Epidemiology & Public Health Poster I: COVID-19 & Vaccination (0084–0117)- 8:30AM-10:30AM
-
Abstract Number: 0395
RNA Polymerase III Autoantibody Levels and Risk of Systemic Sclerosis in Patients with Raynaud Phenomenon